OKI-006, a potent and orally active histone deacetylase (HDAC) inhibitor, stands as a distinctive derivative of the natural product HDAC inhibitor, largazole. By targeting HDACs—key players in epigenomic regulation whose dysfunction often occurs in numerous human cancers—OKI-006 holds promise for cancer research applications [1].